Topic: Pharmaceuticals Sector
(Reuters) - AstraZeneca went back to court on Wednesday to defend the U.S. patent on its multibillion-dollar cholesterol fighter Crestor in the face of an appeal by generic drugmakers.Industry analysts believe the British company is likely to win the case, protecting exclusivity ...
BOSTON (Reuters) - Targacept Inc, a small drugmaker that began life inside the bowels of R.J. Reynolds Tobacco Co, has for years been using its understanding of nicotine to develop experimental treatments for depression, schizophrenia and, yes, smoking cessation.Now it is poised ...
British drugmaker GlaxoSmithKline is in the market to buy assets in India at a total cost of up to $2.0 billion (1.5 billion euros), its chief executive said in an interview published on Monday.Chief executive Andrew Witty told The Times newspaper that ...
AMSTERDAM (Reuters) - Swiss drugmaker Novartis said it has applied to start selling its experimental drug to treat smoker's cough -- which afflicts 80 million people worldwide -- after tests showed that it helped patients breathe more easily.Novartis has carried out late-stage ...
ZURICH (Reuters) - Swiss drugmaker Novartis cut 2,500 jobs at sites across the world in a bid to control costs, the daily Tages Anzeiger reported on Saturday.Like many pharmaceutical companies, Novartis is starting to face generic competition, with its breast cancer drug ...
Swiss pharmaceutical giant Roche has stopped delivering its medicines to some Greek hospitals as they have failed to pay their bills, a spokesman confirmed Sunday."There are hospitals who haven't paid their bills in three or four years," a Roche spokesman said, quoting ...
(Reuters) - Patients with the most serious form of childhood arthritis can get substantial symptom relief from a Novartis drug, researchers said on Friday, raising hopes for a product that had a recent setback in its application to treat gout.Ilaris, or ACZ885, ...
Shortages of vital drugs, particularly cancer-fighting medication, have raised concerns in the United States, where regulators often have to race to try to find replacements.A recent report by the Food and Drug Administration (FDA) found that the number of important treatments that ...
(Reuters) - U.S. drugmaker Eli Lilly & Co is in talks to form a partnership with, and potentially invest in, Turkish generic-drug company Mustafa Nevzat Ilac Sanayii AS (MN Pharmaceuticals), the Wall Street Journal reported, citing people familiar with the matter.The talks, ...
NEW YORK (Reuters) - Pfizer Inc reached a settlement with Dr. Reddy's Laboratories , an Indian drugmaker that has been fighting in court to launch cheaper generic forms of Pfizer's blockbuster cholesterol fighter, the companies said on Wednesday .Dr. Reddy's in 2009 ...
Photo Gallery
-
Art Auction
This photograph provided by Farnsworth Art Museum show the 1969 painting "Portrait ...AP News - -
Pfizer CEO Resigns
FILE - In this Jan. 26, 2009 file photo, Jeffrey Kindler, chairman and ...AP News - -
Eli Lilly Acquisition
FILE - In this Jan. 25, 2006 file photo, the Eli Lilly and ...AP News -
From Around the Web
Video Gallery
-
Indian pharma sector to grow in ...
Kiran Mazumdar Shaw, CMD, Biocon told NDTV Profit that they ...2012-01-09 -
Doing Business with India's Pharmaceutical ...
(www.abndigital.com) India is one of the fastest-growing pharmaceutical ...2011-11-30 -
Pharmaceuticals Industry In India
India is the world's 3rd largest pharmaceutical producer, Cardiovascular ...2011-12-10
